We aimed to clarify the relationship between intra- and periorgan fats, visceral fat, and subcutaneous fat. We used abdominal computed tomography to evaluate intra- and periorgan fat accumulations in the pancreas, liver, spleen, renal parenchyma, renal sinus, and skeletal muscle. The relationships between these fats, visceral fat, and subcutaneous fat were examined by using partial correlation and covariance analysis, adjusting for BMI. We found that visceral fat and all intra- and periorgan fat accumulations were positively correlated, whereas subcutaneous fat and accumulations of all intra- and periorgan fats and visceral fat were negatively correlated. Individuals with excessive visceral fat accumulation had significantly greater accumulations of fat in the pancreas, liver, renal sinus, and skeletal muscle than those without excessive visceral fat accumulation (P = 0.01, 0.006, 0.008, and 0.02, respectively). In conclusion, all intra- and periorgan fat accumulations show a positive correlation with visceral fat and a negative correlation with subcutaneous fat, independent of BMI.

Article Highlights
  • Intra- and periorgan fats, visceral fat, and subcutaneous fat are thought to play different physiologic roles, and understanding the impact of the amount and distribution of these fats may contribute to the prevention and treatment of obesity-related diseases.

  • We found that visceral fat and subcutaneous fat have contrasting associations with intra- and periorgan fat accumulations, and excessive visceral fat was significantly associated with intra- and periorgan fat accumulations.

  • Our findings deepen the understanding of the relationships between intra- and periorgan, visceral, and subcutaneous fats and may contribute to the development of future strategies for obesity-related diseases.

Excessive accumulation of visceral fat is known to induce chronic inflammation, hypoxia, high levels of oxidative stress, and abnormal production of adipocytokines, leading to disturbances in glucose and lipid metabolism. Furthermore, in recent years, it has been reported that fat accumulations in intra- and periorgans, such as the pancreas, liver, skeletal muscle, and renal sinus, lead to glucose disturbances (1) and organ dysfunction through inflammation and fibrosis (2–5). Although these conditions have gained attention in connection with intra- and periorgan fats (also known as ectopic fat), the relationships between intra- and periorgan fats, visceral fat, and subcutaneous fat remain unclear. The purpose of this study was to comprehensively evaluate intra- and periorgan fat accumulations (in the pancreas, liver, renal parenchyma, renal sinus, skeletal muscle, and spleen), visceral fat, and subcutaneous fat and clarify the relationships among these fat accumulations.

We recruited patients aged >20 years at Osaka University Hospital, a large 1,086-bed community academic hospital, who underwent abdominal computed tomography (CT) scans for underlying diseases during their inpatient admission or within 3 months before admission between June 2021 and August 2022. We excluded patients with pancreatic diseases (e.g., pancreatic tumor, pancreatitis), liver diseases (hepatitis, liver cirrhosis), kidney diseases (kidney cancer, end-stage renal disease), adrenal diseases (Cushing syndrome, pheochromocytoma), and acute-stage infections. Approval for the study was granted by the institutional ethics review board of Osaka University Hospital (Suita, Japan), with the assigned approval number 21062. Participants were provided with information about the study and gave written consent to participate.

Assessment of Fat Accumulation

We used unenhanced CT attenuation to gauge the extent of intra- and periorgan fats, which have been shown to have a robust correlation with histologically determined organ fat content (6). As previously reported (7), we computed the CT attenuation for the pancreas by averaging the attenuations from three 1-cm2 regions within the pancreas (head, body, and tail). These measurements were executed meticulously, with the exclusion of the pancreatic duct and margins from the selected areas. Similarly, the CT attenuation for the liver was ascertained by calculating the average CT attenuations from three 1-cm2 regions within the liver (anterior, posterior, and lateral). For skeletal muscle fat, we measured the CT attenuation of the psoas major muscle at the L3 level. The CT attenuations of the spleen and renal parenchyma were determined by calculating the average CT attenuations of three 1-cm2 regions of each organ (upper, middle, and lower). Our previous study regarding interrater reliability showed an intraclass correlation coefficient of 0.86 to 0.98 (7). The images were analyzed using the Aquarius Net Viewer (TeraRecon, Inc., Tokyo, Japan). Renal sinus fat accumulation was measured volumetrically using the Aquarius iNtuition (TeraRecon, Inc.). Adipose tissue was identified using pixel density measured in Hounsfield units (HU), with a specified range of −195 to −45 HU for analysis (8). We used the Synapse Vincent system (Fujifilm, Inc., Tokyo, Japan) to measure the visceral fat area (VFA) and subcutaneous fat area at the navel level. All CT scanning was performed with a slice thickness of 5 mm.

Statistical Analysis

According to the previously reported method (5), the attenuations of the pancreas, liver, spleen, muscle, and renal parenchyma were inverted so that higher values corresponded to more fat. We examined the relationships among visceral fat, subcutaneous fat, and intra- and periorgan fats using the partial correlation coefficient, corrected for age, sex, and BMI. We also performed subgroup analyses separately for men and women. We then divided the participants into the visceral fat accumulation group (VFA ≥100 cm2) and the nonvisceral fat accumulation group (VFA <100 cm2), according to the criteria validated in Japanese (9), performed an ANCOVA adjusting for BMI, and investigated the relationship between the presence of visceral fat accumulation and intra- and periorgan fat accumulations. We conducted statistical analyses using R software (version 4.2.2; https://www.r-project.org/), and statistical significance was determined at a two-sided P value <0.05.

Data and Resource Availability

The data sets analyzed in the current study are available from the corresponding author upon reasonable request. No applicable resources were generated or analyzed during the current study.

Ultimately, 84 patients were enrolled (Supplementary Fig. 1). Characteristics of the patients are listed in Table 1. Visceral fat was significantly positively correlated with liver fat, renal sinus fat, and skeletal muscle fat (r = 0.29 and P = 0.007, r = 0.38 and P < 0.001, and r = 0.25 and P = 0.02, respectively), whereas visceral fat and subcutaneous fat were significantly negatively correlated (r = −0.42 and P < 0.001) (Fig. 1). Whereas visceral fat was positively correlated with all intra- and periorgan fats, subcutaneous fat was negatively correlated with all intra- and periorgan fats (Supplementary Fig. 2). In subgroup analysis, men had significantly higher levels of liver and visceral fats, whereas women had significantly higher levels of subcutaneous fat (Supplementary Table 1). The significant associations between each fat remained consistent when we analyzed the correlations separately in men and women (Supplementary Fig. 3).

Table 1

Clinical characteristics of the participants

N = 84
Age, years 64.0 (49.8, 73.3) 
Sex  
 Male 43 
 Female 41 
BMI, kg/m2 24.6 (21.6, 29.1) 
Pancreas attenuation, HU 38.9 (31.5, 44.9) 
Liver attenuation, HU 57.4 (50.8, 62.1) 
Spleen attenuation, HU 48.9 (45.8, 51.6) 
Skeletal muscle attenuation, HU 47.4 (42.1, 51.9) 
Renal parenchyma attenuation, HU 33.9 (31.8, 36.4) 
Renal sinus fat volume, cm3 4.5 (1.6, 8.7) 
Visceral fat area, cm2 113.1 (81.6, 163.5) 
Subcutaneous fat area, cm2 155.5 (110.0, 229.0) 
Type 2 diabetes 57 
 Use of metformin 27 
 Use of insulin 21 
 Use of SGLT2 inhibitor 15 
 Use of GLP-1 receptor agonist 
 Use of TZD 
Reason for admission  
 Management of diabetes 47 
 Assessment of adrenal function 11 
 Primary hyperparathyroidism evaluation 10 
 Improvement of obesity 
 Assessment of pituitary function 
 Examination of anemia 
 Treatment of thyroid cancer 
 Other 
Reason for CT  
 Examination of adrenal glands 21 
 Preoperative evaluation 18 
 Screening for malignant tumors 14 
 Examination of pancreas 
 Assessment of malignant tumor 
 Postoperative evaluation 
 Examination of liver 
 Examination of abdominal pain 
 Examination of anemia 
 Other 
N = 84
Age, years 64.0 (49.8, 73.3) 
Sex  
 Male 43 
 Female 41 
BMI, kg/m2 24.6 (21.6, 29.1) 
Pancreas attenuation, HU 38.9 (31.5, 44.9) 
Liver attenuation, HU 57.4 (50.8, 62.1) 
Spleen attenuation, HU 48.9 (45.8, 51.6) 
Skeletal muscle attenuation, HU 47.4 (42.1, 51.9) 
Renal parenchyma attenuation, HU 33.9 (31.8, 36.4) 
Renal sinus fat volume, cm3 4.5 (1.6, 8.7) 
Visceral fat area, cm2 113.1 (81.6, 163.5) 
Subcutaneous fat area, cm2 155.5 (110.0, 229.0) 
Type 2 diabetes 57 
 Use of metformin 27 
 Use of insulin 21 
 Use of SGLT2 inhibitor 15 
 Use of GLP-1 receptor agonist 
 Use of TZD 
Reason for admission  
 Management of diabetes 47 
 Assessment of adrenal function 11 
 Primary hyperparathyroidism evaluation 10 
 Improvement of obesity 
 Assessment of pituitary function 
 Examination of anemia 
 Treatment of thyroid cancer 
 Other 
Reason for CT  
 Examination of adrenal glands 21 
 Preoperative evaluation 18 
 Screening for malignant tumors 14 
 Examination of pancreas 
 Assessment of malignant tumor 
 Postoperative evaluation 
 Examination of liver 
 Examination of abdominal pain 
 Examination of anemia 
 Other 

Values are median (first quartile, third quartile) for continuous variables and n of participants for categorical variables.

GLP-1, glucagon-like peptide 1; SGLT2, sodium–glucose cotransporter 2; TZD, thiazolidinedione.

Figure 1

Partial correlation of visceral fat, subcutaneous fat, and all intra- and periorgan fats. Numeric values represent correlation coefficients. Line thickness increases with magnitude of the correlation coefficient. *P < 0.05.

Figure 1

Partial correlation of visceral fat, subcutaneous fat, and all intra- and periorgan fats. Numeric values represent correlation coefficients. Line thickness increases with magnitude of the correlation coefficient. *P < 0.05.

Close modal

In addition, the results of the covariance analysis showed that intra- and periorgan fat accumulations in the pancreas, liver, renal sinus, and skeletal muscle were significantly greater in participants with excessive visceral fat accumulation than in those without excessive visceral fat accumulation (Fig. 2).

Figure 2

Scatter plots and regression lines for all intra- and periorgan fats and BMI divided into two groups: VFA ≥100 and <100 cm2. P values are from ANCOVA. A, pancreas fat; B, liver fat; C, renal parenchyma fat; D, spleen fat; E, muscle fat; and F, renal sinus fat. Fats are shown with the axis of CT attenuation (HU) inverted in AE.

Figure 2

Scatter plots and regression lines for all intra- and periorgan fats and BMI divided into two groups: VFA ≥100 and <100 cm2. P values are from ANCOVA. A, pancreas fat; B, liver fat; C, renal parenchyma fat; D, spleen fat; E, muscle fat; and F, renal sinus fat. Fats are shown with the axis of CT attenuation (HU) inverted in AE.

Close modal

This study revealed that subcutaneous and visceral fats had contrasting associations with intra- and periorgan fat accumulations, after adjustment for BMI. In partial correlations, subcutaneous fat was inversely correlated with both visceral fat and intra- and periorgan fats, whereas visceral fat was positively correlated with all intra- and periorgan fat accumulations. These correlations suggest that subcutaneous fat acts protectively against accumulations of visceral fat and intra- and periorgan fats. Although there have been several previous studies reporting that increased visceral fat is associated with accumulations of fat in the liver (10) and pancreas (11), to our knowledge, this is the first study to report the comprehensive interrelationships of intra- and periorgan fat accumulations, particularly the negative association of subcutaneous fat accumulation with visceral fat and intra- and periorgan fat accumulations.

Subcutaneous fat represents a proper expansion of adipocytes and can therefore be considered a protective fat depot (12). Excess visceral fat deposition is speculated to occur because of the relative dysfunction of subcutaneous adipose tissue (13). A previous study reported that compared with individuals with more subcutaneous fat and more visceral fat, those with less subcutaneous fat and more visceral fat had a higher prevalence of hypertriglyceridemia (14). Individuals with less subcutaneous fat and more visceral fat may lack sufficient adipocytes and have limited capacity to store fat in adipose tissue, resulting in intra- and periorgan fat storage (14).

By comparing the participants with and without excessive visceral fat accumulation, we showed that visceral fat was significantly related to intra- and periorgan fat accumulations (pancreas, liver, skeletal muscle, and renal sinus) after adjusting for BMI. Because BMI is more correlated with subcutaneous fat than with visceral fat (9), it seems more appropriate to refer to visceral fat content rather than BMI to assess intra- and periorgan fat accumulations. In this analysis, skeletal muscle fat showed a different direction in relation to BMI than other intra- and periorgan fats. This might be because, especially in elderly individuals, a lower BMI can enhance muscle loss and sarcopenia, leading to an increase in skeletal muscle fat.

In the current study, there was no relationship between renal parenchyma fat, spleen fat, and visceral fat. The renal parenchyma accumulates an extremely small amount of fat compared with the inside of the renal sinus, and the spleen is an organ often used as a control, such as in the liver-spleen contrast, and is considered to be an organ in which intra- and periorgan fats are unlikely to accumulate.

In the subgroup analysis separated by sex, we found that men had significantly higher levels of liver fat, renal sinus fat, and visceral fat, whereas women had significantly higher levels of subcutaneous fat. These results are consistent with previous reports showing that men accumulate more liver fat (15) and renal sinus fat (16).

The strength of the current study is its analysis of a comprehensive set of fat compartments and its focus on partial correlations rather than simple two-way correlations, because fat compartments are highly interrelated. Our approach allowed assessment of the independent correlation of each fat and revealed the biologically inverse correlation between subcutaneous and visceral fat.

There are several limitations in this study that should be noted. First, the study group comprised a small number of hospitalized Asian patients who underwent CT scans. Therefore, the associations observed in the current study may not necessarily apply to other ethnic groups or individuals who are not hospitalized. Further investigation with larger sample sizes will be required. Second, there was no histologic verification of intra- and periorgan fats in our study. However, the assessment technique used in this study has been validated in a prior study, revealing significant correlations between CT attenuation and histologically determined fat levels (6). Third, the CT scanners used in this study were not uniform, and scans were obtained under varying imaging conditions with different tube voltages. Fourth, this study measured subcutaneous trunk fat and did not measure gluteal/femoral fat. Gluteal/femoral fat has been reported to have different lipolytic properties compared with subcutaneous trunk adipose tissue, potentially having a more protective effect on the human body. Future investigations using midthigh CT scans will be necessary.

In conclusion, we have demonstrated that intra- and periorgan fat accumulations in each organ show a positive correlation with visceral fat accumulation and a negative correlation with subcutaneous fat accumulation, independent of BMI.

This article contains supplementary material online at https://doi.org/10.2337/figshare.25664538.

Acknowledgments. The authors thank the staff of TeraRecon, Inc., Tokyo, Japan, for explaining how to measure renal sinus fat.

Funding. This study was supported by the Grants-in-Aid for Scientific Research program of the Japan Society for the Promotion of Science (grant 21K17660).

Duality of Interest. M.Y.B. and H.O. belong to the Department of Lifestyle Medicine, which is a sponsored course endowed by Kubara Honke Co., Ltd. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. K.M. and M.Y.B. conceived and designed the study, performed statistical analysis, and drafted the manuscript. K.M., M.Y.B., T.K., S.K., A.N., R.T., T.H., H.O., C.I., Y.H., Y.F., and J.K. interpreted the data. J.K. and I.S. critically revised the manuscript. All authors participated in the writing process of the manuscript and gave their final approval of both the submitted and published versions. M.Y.B. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. Parts of this study were presented at the 43rd Japan Society for the Study of Obesity, Okinawa, Japan, 2–3 December 2022.

1.
Martin
S
,
Sorokin
EP
,
Thomas
EL
, et al
.
Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: a Mendelian randomization study
.
Diabetes Care
2022
;
45
:
460
468
2.
Petrov
MS
.
Fatty change of the pancreas: the Pandora’s box of pancreatology
.
Lancet Gastroenterol Hepatol
2023
;
8
:
671
682
3.
Montani
JP
,
Carroll
JF
,
Dwyer
TM
,
Antic
V
,
Yang
Z
,
Dulloo
AG
.
Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases
.
Int J Obes Relat Metab Disord
2004
;
28
(
Suppl. 4
):
S58
S65
4.
Foster
MC
,
Hwang
SJ
,
Porter
SA
,
Massaro
JM
,
Hoffmann
U
,
Fox
CS
.
Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study
.
Hypertension
2011
;
58
:
784
790
5.
Yamazaki
H
,
Tauchi
S
,
Machann
J
, et al
.
Fat distribution patterns and future type 2 diabetes
.
Diabetes
2022
;
71
:
1937
1945
6.
Kim
SY
,
Kim
H
,
Cho
JY
, et al
.
Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications
.
Radiology
2014
;
271
:
104
112
7.
Mitsushio
K
,
Baden
MY
,
Kato
S
, et al
.
Relationships between intra-pancreatic fat deposition and lifestyle factors: a cross-sectional study
.
Front Endocrinol (Lausanne)
2023
;
14
:
1219579
8.
Foster
MC
,
Hwang
SJ
,
Porter
SA
,
Massaro
JM
,
Hoffmann
U
,
Fox
CS
.
Development and reproducibility of a computed tomography-based measurement of renal sinus fat
.
BMC Nephrol
2011
;
12
:
52
9.
Examination Committee of Criteria for ‘Obesity Disease’ in Japan
;
Japan Society for the Study of Obesity
.
New criteria for ‘obesity disease’ in Japan
.
Circ J
2002
;
66
:
987
992
10.
Seaw
KM
,
Henry
CJ
,
Bi
X
.
Relationship between non-alcoholic fatty liver disease and visceral fat measured by imaging-based body composition analysis: a systematic review
.
Livers
2023
;
3
:
463
493
11.
Caldart
F
,
de Pretis
N
,
Luchini
C
,
Ciccocioppo
R
,
Frulloni
L
.
Pancreatic steatosis and metabolic pancreatic disease: a new entity?
Intern Emerg Med
2023
;
18
:
2199
2208
12.
Porter
SA
,
Massaro
JM
,
Hoffmann
U
,
Vasan
RS
,
O’Donnel
CJ
,
Fox
CS
.
Abdominal subcutaneous adipose tissue: a protective fat depot?
Diabetes Care
2009
;
32
:
1068
1075
13.
Després
JP
.
Body fat distribution and risk of cardiovascular disease: an update
.
Circulation
2012
;
126
:
1301
1313
14.
Pou
KM
,
Massaro
JM
,
Hoffmann
U
, et al
.
Patterns of abdominal fat distribution: the Framingham Heart Study
.
Diabetes Care
2009
;
32
:
481
485
15.
North
KE
,
Graff
M
,
Franceschini
N
, et al
.
Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI Family Heart Study
.
Eur J Gastroenterol Hepatol
2012
;
24
:
9
16
16.
Couch
CA
,
Fowler
LA
,
Goss
AM
,
Gower
BA
.
Associations of renal sinus fat with blood pressure and ectopic fat in a diverse cohort of adults
.
Int J Cardiol Cardiovasc Risk Prev
2022
;
16
:
200165
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.